Trial Profile
A Single arm, multicenter phase II trial of micafungin for the treatment of febrile neutropenia.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 06 Nov 2015
Price :
$35
*
At a glance
- Drugs Micafungin (Primary)
- Indications Febrile neutropenia
- Focus Therapeutic Use
- 06 Nov 2015 New trial record